Darwin Origin Biopharmaceutical

Darwin Origin Biopharmaceutical is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative regenerative medicines and cell therapies. The company focuses on leveraging mesenchymal stem cells (MSCs) and exosome-based technologies to treat a wide range of conditions, including metabolic diseases, reproductive health issues, and degenerative joint disorders. Their lead programs include advanced treatments for Type 2 diabetes and erectile dysfunction, utilizing proprietary delivery systems to enhance therapeutic efficacy. Darwin Origin aims to bridge the gap between basic stem cell research and clinical application through its integrated R&D and manufacturing capabilities.